Merck announced that the FDA has issued a Complete Response Letter regarding Merck’s Supplemental New Drug Applications for Januvia (sitagliptin),...
Merck & Co and Avanir Pharmaceuticals have entered an agreement to co-promote Merck's portfolio of sitagliptin-based diabetes products in the...